Expression of Notch-1 and Its Ligands, Delta-Like-1 and Jagged-1, Is Critical for Glioma Cell Survival and Proliferation

Benjamin Purow(Cancer Institute (WIA)), Raqeeb Haque(Cancer Institute (WIA)), Martha Noel(Cancer Institute (WIA)), Qin Su(Cancer Institute (WIA)), Michael J. Burdick(Cancer Institute (WIA)), Jeongwu Lee(Cancer Institute (WIA)), Tilak Sundaresan(Cancer Institute (WIA)), Sandra Pastorino(Cancer Institute (WIA)), John K. Park(National Institutes of Health), Irina Mikolaenko(Johns Hopkins University), Dragan Maric(National Institutes of Health), Charles G. Eberhart(Johns Hopkins University), Howard A. Fine(Cancer Institute (WIA))
Cancer Research
March 15, 2005
Cited by 578

Abstract

The Notch family of proteins plays an integral role in determining cell fates, such as proliferation, differentiation, and apoptosis. We show that Notch-1 and its ligands, Delta-like-1 and Jagged-1, are overexpressed in many glioma cell lines and primary human gliomas. Immunohistochemistry of a primary human glioma tissue array shows the presence in the nucleus of the Notch-1 intracellular domain, indicating Notch-1 activation in situ. Down-regulation of Notch-1, Delta-like-1, or Jagged-1 by RNA interference induces apoptosis and inhibits proliferation in multiple glioma cell lines. In addition, pretreatment of glioma cells with Notch-1 or Delta-like-1 small interfering RNA significantly prolongs survival in a murine orthotopic brain tumor model. These results show, for the first time, the dependence of cancer cells on a single Notch ligand; they also suggest a potential Notch juxtacrine/autocrine loop in gliomas. Notch-1 and its ligands may present novel therapeutic targets in the treatment of glioma.


Related Papers

No related papers found

Powered by citation graph analysis